Literature DB >> 21042863

Quo vadis multiple sclerosis?

Israel Steiner, Ronit Mosberg-Galili.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21042863     DOI： 10.1007/s10787-010-0067-z

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN： 0925-4692            Impact factor:   4.473


× No keyword cloud information.
  10 in total

1.  Multiple sclerosis--in need of a critical reappraisal.

Authors:  I Steiner; I Wirguin
Journal:  Med Hypotheses       Date:  2000-01       Impact factor: 1.538

Review 2.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

3.  Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study.

Authors:  Peter Sundström; Anders Wåhlin; Khalid Ambarki; Richard Birgander; Anders Eklund; Jan Malm
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

Review 4.  Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis.

Authors:  Subramaniam Sriram; Israel Steiner
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

5.  Have we finally identified an autoimmune demyelinating disease?

Authors:  Moses Rodriguez
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

Review 6.  Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.

Authors:  Elliot M Frohman; Olaf Stüve; Eva Havrdova; John Corboy; Anat Achiron; Robert Zivadinov; Per Soelberg Sorensen; J Theodore Phillips; Brian Weinshenker; Kathleen Hawker; Hans-Peter Hartung; Lawrence Steinman; Scott Zamvil; Bruce A C Cree; Stephen Hauser; Howard Weiner; Michael K Racke; Massimo Filippi
Journal:  Arch Neurol       Date:  2005-10

7.  No cerebrocervical venous congestion in patients with multiple sclerosis.

Authors:  Florian Doepp; Friedemann Paul; José M Valdueza; Klaus Schmierer; Stephan J Schreiber
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

8.  How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

Authors:  M G Brown; S Kirby; C Skedgel; J D Fisk; T J Murray; V Bhan; I S Sketris
Journal:  Neurology       Date:  2007-08-15       Impact factor: 9.910

Review 9.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

10.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.

Authors:  P Zamboni; R Galeotti; E Menegatti; A M Malagoni; G Tacconi; S Dall'Ara; I Bartolomei; F Salvi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-12-05       Impact factor: 10.154
  10 in total
  1 in total

Review 1.  The conundrum of iron in multiple sclerosis--time for an individualised approach.

Authors:  Susan J van Rensburg; Maritha J Kotze; Ronald van Toorn
Journal:  Metab Brain Dis       Date:  2012-03-17       Impact factor: 3.584
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.